首页>
外国专利>
Combination therapy for treating malignant blood disorders using pyridopyrimidinone PI3K / MTOR inhibitors with bendamustine and / or rituximab
Combination therapy for treating malignant blood disorders using pyridopyrimidinone PI3K / MTOR inhibitors with bendamustine and / or rituximab
展开▼
机译:吡嘧嘧啶酮PI3K / MTOR抑制剂与苯达莫司汀和/或利妥昔单抗联合治疗恶性血液病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides a method for treating cancers including hematologic malignancies comprising administering a compound of Formula (I): in combination with one or both of bendamustine and rituximab.
展开▼